Genzyme Needs to Update Its Merger Status (GENZ, SNY, PFE, AMGN, JNJ)
Genzyme Corporation (NASDAQ: GENZ) still has an incredible merger ‘deal premium’ associated with it over a pending Sanofi-Aventis (NYSE: SNY) buyout. Genzyme’s troubles have left it vulnerable to a deal for a while now,…